Ovarian Cancer Therapy
New ovarian cancer therapy study findings recently were published by J.R. Cubillos-Ruiz and co-researchers
Published in Cancer Law Weekly, February 13th, 2010
A report, 'Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes,' is newly published data in Cell Cycle. According to recent research published in the journal Cell Cycle, "Current therapies for metastatic ovarian carcinoma are based on surgical debulking followed by chemotherapy. After more than three decades implementing treatments that selectively target the tumor cell, the 5-year survival rate for metastatic ovarian cancer patients is still lower than 30%."
"Novel strategies are therefore urgently needed to complement classical treatments for this malignancy. Recently, leukocytes in the ovarian cancer microenvironment...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Law Weekly
Source: Cancer Law Weekly (2010-02-13)
More Articles from Cancer Law Weekly
- American Academy of Dermatology
American Academy of Dermatology Lauds U.S. Federal Trade Commission for Protecting the Public From False Health and Safety Claims About Indoor Tanning - Asbestos Disease Awareness Organization ADAO
Asbestos Disease Awareness Organization ADAO Announces New Staff and Program for 2010 - Biomoda, Inc.
Biomoda Supports Nebraska Legislation to Screen Veterans for Lung Cancer - Chase
Five California Charities Win Grants from Chase Through Facebook Program - Life Sciences
New findings from University of Surrey in the area of life sciences published - Pancreatic Cancer Action Network
President Obama's State of the Union Address: a Statement From the Pancreatic Cancer Action Network - More from this issue of Cancer Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
